key: cord-0941946-p21g4eqo
authors: Lozada‐Martínez, Ivan David; Díaz‐Castillo, Oscar Javier; Pearson‐Arrieta, Angely Carolina; Galeano‐Buelvas, Alexandra; Moscote‐Salazar, Luis Rafael
title: Post‐COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia
date: 2021-09-05
journal: Alzheimers Dement
DOI: 10.1002/alz.12459
sha: 2969c4e1c8ce08c4f29edf2b95d7b8b44cda34f2
doc_id: 941946
cord_uid: p21g4eqo

nan

Dear Editor,

We read with great interest the article published by Wang et al., 1 where the authors conducted a study of electronic medical records of 61.9 million patients over the age of 18 in the United States. There is evidence supporting the view that neurotropic respiratory viruses cause chronic brain pathology. Coronaviruses, especially β-coronaviruses, a group to which SARS-CoV-2 belongs, have a high affinity for the central nervous system, generating neurovascular, neurofunctional, inflammatory, and metabolic complications, 2 thus affecting functional capacity, especially in those with a history of chronic neurological diseases. 3 The inflammatory process reaction triggered by contact between the viral agent and cellular and endothelial receptors, with the release of cytokines such as IL-10 and CC14, which cause disruption of the blood-brain barrier in the central nervous system, leading to a state of hypercoagulability through microthrombotic processes. 4 Additionally, in response to inflammatory stimuli in neuronal tissue, the apolipoprotein ε4 genotype factors in the senescence of different cell types in the nervous system, favoring a rapidly progressive deterioration of the cognitive and motor activity of the affected person; therefore, it is to be expected that people with dementia are at increased risk of presenting an aggressive COVID-19 phenotype with obvious neurological manifestations, and furthermore, during the post-COVID neurological syndrome period (a time window lasting between months and years), a visible deterioration in the baseline dementia is observed. 5, 6 This is without taking into account the presence of classic cardiovascular risk factors such as hypertension, diabetes mellitus, smoking, sedentary lifestyle, age and/or a history of cerebral ischemic events, which worsen the neurological prognosis of these patients. 5 The neuropsychiatric manifestations of the post-COVID neurological syndrome described so far include muscle weakness and other forms of myopathies, depression, anxiety, impaired sleep quality, posttraumatic stress syndrome, muscular pain, headache, dizziness, fatigue, and persistent anosmia, 4, 7, 8, 9 and the actual impact on the progression of previously diagnosed neurodegenerative diseases is unknown.

Imaging and neurofunctional studies reveal nonspecific and variable changes in the brain, 10 so it is essential to design and maintain ongoing prospective multicenter studies to evaluate the effect of SARS-Cov-2 neuroinvasion over time.

Considering that no study provides conclusive evidence, due to the time window of the COVID-19 pandemic course, on the association between this viral disease and dementia, we therefore suggest taking into account the post-COVID-19 neurological syndrome as an important risk factor for the progression and severity of dementia, in order to analyze and evaluate the course of those affected by COVID-19 who previously had this condition, and if necessary, to propose as well new risk stratification models to control the morbimortality of this population. To this end, we also propose the design of a specialized group to strictly monitor patients with dementia, in order to avoid the loss of data during the evaluation periods, to identify early this subgroup

COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US

Acute and post-acute neurological complications of COVID-19

The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning

Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community

The effects of the COVID-19 pandemic on people with dementia

Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Analysis of psychological and sleep state of medical stuff with novel coronavirus pneumonia

Letter to the editor. Healthcare workers on the edge of sanity due to COVID-19: rapid review of the results of systematic reviews and meta-analyzes

Spectrum of neurologic & neuroimaging manifestation in COVID-19